Microphthalmia, persistent hyperplastic hyaloid vasculature and lens anomalies following overexpression of VEGF-A188 from the αA-crystallin promoter

Molecular Vision

Volumn 13, Issue , 2007, Pages 47-56

  Rutland, Catrin S ^a   Mitchell, Christopher A ^b   Nasir, Muneeb ^a   Konerding, Moritz A ^c   Drexler, Hannes C A ^d,e  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^e UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CRYSTALLIN; ALPHA SMOOTH MUSCLE ACTIN; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN A 188;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATARACT; CELL COUNT; CELL TYPE; CONTROLLED STUDY; CORNEA THICKNESS; ENDOTHELIUM CELL; EYE DEVELOPMENT; FEMALE; GENE OVEREXPRESSION; HYPERPLASIA; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; IRIS; LENS DISEASE; MALE; MICROPHTHALMIA; MOUSE; NEWBORN; NONHUMAN; OCULAR BLOOD VESSEL; PERICYTE; PERSISTENT HYPERPLASTIC PRIMARY VITREOUS; PRIORITY JOURNAL; PROMOTER REGION; RETINA; STEREOLOGY; TRANSGENIC MOUSE; WILD TYPE;

ABNORMALITIES; ACTINS; ALPHA-CRYSTALLIN A CHAIN; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, DIFFERENTIATION; BLOOD VESSELS; CELL COUNT; CORNEA; DISEASE MODELS, ANIMAL; EMBRYO; ENDOTHELIAL CELLS; EYE; HEPARAN SULFATE PROTEOGLYCANS; HYPERPLASIA; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; LENS, CRYSTALLINE; MICE; MICE, TRANSGENIC; MICROPHTHALMOS; MYOCYTES, SMOOTH MUSCLE; PERICYTES; PROMOTER REGIONS (GENETICS); VASCULAR DISEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846501549     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Ash JD, Overbeek PA. Lens-specific VEGF-A expression induces angioblast migration and proliferation and stimulates angiogenic remodeling. Dev Biol 2000; 223:383-98.
2. Reneker LW, Overbeek PA. Lens-specific expression of PDGF-A alters lens growth and development. Dev Biol 1996; 180:554-65.
3. Tanaka T, Saika S, Ohnishi Y, Ooshima A, McAvoy JW, Liu CY, Azhar M, Doetschman T, Kao WW. Fibroblast growth factor 2: roles of regulation of lens cell proliferation and epithelial-mesenchymal transition in response to injury. Mol Vis 2004; 10:462-7.
4. Miquerol L, Langille BL, Nagy A. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development 2000; 127:3941-6.
5. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380:439-42.
6. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380:435-9.
7. Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L, Wright BD, Radtke F, Aguet M, Ferrara N. VEGF is required for growth and survival in neonatal mice. Development 1999; 126:1149-59.
8. Mitchell CA, Risau W, Drexler HC. Regression of vessels in the tunica vasculosa lentis is initiated by coordinated endothelial apoptosis: a role for vascular endothelial growth factor as a survival factor for endothelium. Dev Dyn 1998; 213:322-33.
9. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13:18-32.
10. Shima DT, Kuroki M, Deutsch U, Ng YS, Adamis AP, D'Amore PA. The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J Biol Chem 1996; 271:3877-83.
11. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246:1306-9.
12. Park JE, Keller GA, Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the sub-epithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 1993; 4:1317-26.
13. Ng YS, Rohan R, Sunday ME, Demello DE, D'Amore PA. Differential expression of VEGF isoforms in mouse during development and in the adult. Dev Dyn 2001; 220:112-21.
14. Davies MJ, Mitchell CA, Maley MA, Grounds MD, Harvey AR, Plant GW, Wood DJ, Hong Y, Chirila TV. In vitro assessment of the biological activity of basic fibroblast growth factor released from various polymers and biomatrices. J Biomater Appl 1997; 12:31-56.
15. Sone H, Kawakami Y, Segawa T, Okuda Y, Sekine Y, Honmura S, Segawa T, Suzuki H, Yamashita K, Yamada N. Effects of intraocular or systemic administration of neutralizing antibody against vascular endothelial growth factor on the murine experimental model of retinopathy. Life Sci 1999; 65:2573-80.
16. Zhang W, Ito Y, Berlin E, Roberts R, Luan H, Berkowitz BA. Specificity of subnormal deltaPO2 for retinal neovascularization in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci 2003; 44:3551-5.
17. Ahmed A, Dunk C, Ahmad S, Khaliq A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen - a review. Placenta 2000; 21 Suppl A:S16-24.
18. Okamoto N, Tobe T, Hackett SF, Ozaki H, Vinores MA, LaRochelle W, Zack DJ, Campochiaro PA. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol 1997; 151:281-91.
19. Mitchell CA, Rutland CS, Walker M, Nasir M, Foss AJ, Stewart C, Gerhardt H, Konerding MA, Risau W, Drexler HC. Unique vascular phenotypes following over-expression of individual VEGFA isoforms from the developing lens. Angiogenesis 2006; 9:209-24.
20. Gundersen HJ, Jensen EB. The efficiency of systematic sampling in stereology and its prediction. J Microsc 1987; 147:229-63.
21. Mayhew TM, Burton GJ. Methodological problems in placental morphometry: apologia for the use of stereology based on sound sampling practice. Placenta 1988; 9:565-81.
22. Saint-Geniez M, D'Amore PA. Development and pathology of the hyaloid, choroidal and retinal vasculature. Int J Dev Biol 2004; 48:1045-58.
23. Leenen PJ, de Bruijn MF, Voerman JS, Campbell PA, van Ewijk W. Markers of mouse macrophage development detected by monoclonal antibodies. J Immunol Methods 1994; 174:5-19.
24. Zhu M, Provis JM, Penfold PL. The human hyaloid system: cellular phenotypes and inter-relationships. Exp Eye Res 1999; 68:553-63.
25. Morleo M, Pramparo T, Perone L, Gregato G, Le Caignec C, Mueller RF, Ogata T, Raas-Rothschild A, de Blois MC, Wilson LC, Zaidman G, Zuffardi O, Ballabio A, Franco B. Microphthalmia with linear skin defects (MLS) syndrome: clinical, cytogenetic, and molecular characterization of 11 cases. Am J Med Genet A 2005; 137:190-8.
26. Ng D, Hadley DW, Tifft CJ, Biesecker LG. Genetic heterogeneity of syndromic X-linked recessive microphthalmia-anophthalmia: is Lenz microphthalmia a single disorder? Am J Med Genet 2002; 110:308-14.
27. Ng D, Thakker N, Corcoran CM, Donnai D, Perveen R, Schneider A, Hadley DW, Tifft C, Zhang L, Wilkie AO, van der Smagt JJ, Gorlin RJ, Burgess SM, Bardwell VJ, Black GC, Biesecker LG. Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCOR. Nat Genet 2004; 36:411-6.
28. Berger W. Molecular dissection of Norrie disease. Acta Anat (Basel) 1998; 162:95-100.
29. Khaliq S, Hameed A, Ismail M, Anwar K, Leroy B, Payne AM, Bhattacharya SS, Mehdi SQ. Locus for autosomal recessive nonsyndromic persistent hyperplastic primary vitreous. Invest Ophthalmol Vis Sci 2001; 42:2225-8.
30. Kawamura M, Azuma N. Morphological studies on cataract and small lens formation in neonatal rats treated with monosodium-L-glutamate. Ophthalmic Res 1992; 24:289-97.
31. Roberts SR. Color dilution and hereditary defects in collie dogs. Am J Ophthalmol 1967; 63:1762-75.
32. Unoki K, Nakao K, Ohba N. Haemorrhage in the lens: spontaneous occurrence in congenital cataract. Br J Ophthalmol 1986; 70:593-5.
33. Federman JL, Shields JA, Altman B, Koller H. The surgical and nonsurgical management of persistent hyperplastic primary vitreous. Ophthalmology 1982; 89:20-4.
34. Neely KA, Gardner TW. Ocular neovascularization: clarifying complex interactions. Am J Pathol 1998; 153:665-70.
35. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, Jeltsch M, Mitchell C, Alitalo K, Shima D, Betsholtz C. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 2003; 161:1163-77.
36. Benjamin LE, Keshet E. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci U S A 1997; 94:8761-6.
37. Drake CJ, Little CD. Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. Proc Natl Acad Sci U S A 1995; 92:7657-61.
38. Hagedorn M, Balke M, Schmidt A, Bloch W, Kurz H, Javerzat S, Rousseau B, Wilting J, Bikfalvi A. VEGF coordinates interaction of pericytes and endothelial cells during vasculogenesis and experimental angiogenesis. Dev Dyn 2004; 230:23-33.
39. Giavazzi R, Sennino B, Coltrini D, Garofalo A, Dossi R, Ronca R, Tosatti MP, Presta M. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. Am J Pathol 2003; 162:1913-26.
40. Witmer AN, van Blijswijk BC, van Noorden CJ, Vrensen GF, Schlingemann RO. In vivo angiogenic phenotype of endothelial cells and pericytes induced by vascular endothelial growth factor-A. J Histochem Cytochem 2004; 52:39-52.
41. Fruttiger M. Development of the mouse retinal vasculature: angiogenesis versus vasculogenesis. Invest Ophthalmol Vis Sci 2002; 43:522-7.
42. Kusters B, Leenders WP, Wesseling P, Smits D, Verrijp K, Ruiter DJ, Peters JP, van Der Kogel AJ, de Waal RM. Vascular endothelial growth factor-A(165) induces progression of melanoma brain metastases without induction of sprouting angiogenesis. Cancer Res 2002; 62:341-5.
43. Lobov IB, Rao S, Carroll TJ, Vallance JE, Ito M, Ondr JK, Kurup S, Glass DA, Patel MS, Shu W, Morrisey EE, McMahon AP, Karsenty G, Lang RA. WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature 2005; 437:417-21.
44. Haigh JJ, Morelli PI, Gerhardt H, Haigh K, Tsien J, Damert A, Miquerol L, Muhlner U, Klein R, Ferrara N, Wagner EF, Betsholtz C, Nagy A. Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling. Dev Biol 2003; 262:225-41.
45. Chen YG, Zhang C, Chiang SK, Wu T, Tso MO. Increased nuclear factor-kappa B p65 immunoreactivity following retinal ischemia and reperfusion injury in mice. J Neurosci Res 2003; 72:125-31.
46. Pico JF, Stamper RL, McMenemy M. Intraocular pressure and corneal curvature changes on application of limbal-scleral suction fixation ring in rabbits. Cornea 1993; 12:25-8.
47. Setala K, Vannas A. Corneal endothelial cells in essential iris atrophy. A specular microscipic study. Acta Ophthalmol (Copenh) 1979; 57:1020-9.
48. Herndon LW, Choudhri SA, Cox T, Damji KF, Shields MB, Allingham RR. Central corneal thickness in normal, glaucomatous, and ocular hypertensive eyes. Arch Ophthalmol 1997; 115:1137-41.
49. Copt RP, Thomas R, Mermoud A. Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma. Arch Ophthalmol 1999; 117:14-6.
50. Brusini P, Miani F, Tosoni C. Corneal thickness in glaucoma: an important parameter? Acta Ophthalmol Scand Suppl 2000; 78:41-2.
51. Brandt JD, Beiser JA, Kass MA, Gordon MO. Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology 2001; 108:1779-88.
52. Herman DC, Hodge DO, Bourne WM. Increased corneal thickness in patients with ocular hypertension. Arch Ophthalmol 2001; 119:334-6.
53. Singh RP, Goldberg I, Graham SL, Sharma A, Mohsin M. Central corneal thickness, tonometry, and ocular dimensions in glaucoma and ocular hypertension. J Glaucoma 2001; 10:206-10.
54. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219:983-5.
55. Gogat K, Le Gat L, Van Den Berghe L, Marchant D, Kobetz A, Gadin S, Gasser B, Quere I, Abitbol M, Menasche M. VEGF and KDR gene expression during human embryonic and fetal eye development. Invest Ophthalmol Vis Sci 2004; 45:7-14.
56. Lip PL, Blann AD, Hope-Ross M, Gibson JM, Lip GY. Agerelated macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. Ophthalmology 2001; 108:705-10.
57. Tripathi RC, Tripathi BJ. Lens morphology, aging, and cataract. J Gerontol 1983; 38:258-70.
58. Pangtey MS, Khokhar S, Sony P, Panda A, Sethi HS, Chandra P. Posttraumatic neovascularization in a cataractous crystalline lens. J Cataract Refract Surg 2003; 29:859-60; author reply 860-1.
59. Hwang YS, Lai CC, Lee JS, Yang KJ, Chen TL. Posttraumatic neovascularization in a cataractous crystalline lens. J Cataract Refract Surg 2002; 28:715-6.
60. Bene C, Hutchins R, Kranias G. Cataract wound neovascularization. An often overlooked cause of vitreous hemorrhage. Ophthalmology 1989; 96:50-3.
61. Silbert M, Gurwood AS. Persistent hyperplastic primary vitreous. Clin. Eye Vis. Care 2000; 12:131-137.
62. Reichel MB, Ali RR, D'Esposito F, Clarke AR, Luthert PJ, Bhattacharya SS, Hunt DM. High frequency of persistent hyperplastic primary vitreous and cataracts in p53-deficient mice. Cell Death Differ 1998; 5:156-62.
63. Allgoewer I, Pfefferkorn B. Persistent hyperplastic tunica vasculosa lentis and persistent hyperplastic primary vitreous (PHTVL/PHPV) in two cats. Vet Ophthalmol 2001; 4:161-4.
64. Bayon A, Tovar MC, Fernandez del Palacio MJ, Agut A. Ocular complications of persistent hyperplastic primary vitreous in three dogs. Vet Ophthalmol 2001; 4:35-40.
65. Gionfriddo JR, Blair M. Congenital cataracts and persistent hyaloid vasculature in a llama (Lama glama). Vet Ophthalmol 2002; 5:65-70.